Who Will Be the Next Oncology Giant? Axsome and Madrigal Could Overtake by 2026 

Life Science

Corcept Surges Nearly 20% as FDA Approves Ovarian Cancer Drug Lifyorli

Life Science

Impressive Performance but Undervalued Stocks, Can Moody’s Corporation and Pool Corp Reverse the Trend?

Consumer Goods, Life Science

Tarsus Pharmaceuticals Chief Human Resources Officer Sells Shares, Transaction Highlights Company’s Commercial Momentum

Life Science

Eli Lilly’s Weight-Loss Bet Comes With Risk. This ETF Offers a Smarter Alternative

Life Science

Is Bristol Myers Squibb’s 4.4% Dividend Yield Too Good to Be True?

Life Science

Market Turmoil Got You on Edge? These Three Stocks Could Be Your Anchor

Life Science, Technology

April 10 Looms as Eli Lilly’s Next Big Test: Is the Stock a Buy Before the FDA Verdict?

Life Science

An Institution Increases Holdings in Sotera Health Against the Trend

Life Science

A Tale of Two Pharma Giants — Bet on the Future or Cash In on Dividends?

Life Science

Jamieson Wellness: Unlocking the Investment Potential Behind the Green Cap

Consumer Goods, Life Science

Hims & Hers Joins Hands with Former Rival, Hidden Concerns Loom Over the Weight Loss Drug Market Landscape

Life Science

Two Top Analysts Just Upgraded Edgewise Therapeutics. Here’s Why.

Life Science

How is Pfizer Tackling the “Blockbuster Drug Drought” in the Post-Pandemic Era?

Life Science

Insider Cashes Out, Hedge Fund Piles In: The Two Faces of Olema After a 300% Rally

Life Science